SAR 31.95
(2.4%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 11.39 Million SAR | -40.28% |
2022 | 19.07 Million SAR | 144.26% |
2021 | 7.81 Million SAR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 1.98 Million SAR | 3175.16% |
2023 Q2 | 11.33 Million SAR | -7.39% |
2023 Q4 | 60.47 Thousand SAR | -99.47% |
2023 FY | 11.39 Million SAR | -40.28% |
2022 Q2 | 6.84 Million SAR | 0.0% |
2022 FY | 19.07 Million SAR | 144.26% |
2022 Q4 | 12.23 Million SAR | 78.9% |
2021 FY | 7.81 Million SAR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Middle East Pharmaceutical Industries Co. | 65.82 Million SAR | 82.693% |
Al-Dawaa Medical Services Company | 329.22 Million SAR | 96.539% |
Nahdi Medical Company | 892.61 Million SAR | 98.724% |
Al-Razi Medical Co. | 685.96 Thousand SAR | -1560.858% |